
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
Jiankang Jin, Katsuhiro Yoshimura, Matheus Sewastjanow‐Silva, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4352-4352
Open Access | Times Cited: 38
Jiankang Jin, Katsuhiro Yoshimura, Matheus Sewastjanow‐Silva, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4352-4352
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
SERS in 3D cell models: a powerful tool in cancer research
Lara Troncoso-Afonso, Gail A. Vinnacombe‐Willson, Clara García‐Astrain, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 5118-5148
Open Access | Times Cited: 17
Lara Troncoso-Afonso, Gail A. Vinnacombe‐Willson, Clara García‐Astrain, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 10, pp. 5118-5148
Open Access | Times Cited: 17
Prediction of Patient Drug Response via 3D Bioprinted Gastric Cancer Model Utilized Patient‐Derived Tissue Laden Tissue‐Specific Bioink
Yoo‐mi Choi, Deukchae Na, Goeun Yoon, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Yoo‐mi Choi, Deukchae Na, Goeun Yoon, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Optimizing Xenograft Models for Breast Cancer: A Comparative Analysis of Cell-Derived and Patient-Derived Implantation Techniques in Pre-Clinical Research
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access | Times Cited: 1
Astrid Feinisa Khairani, Shella Harmonia, Yoan Chou, et al.
Breast Cancer Targets and Therapy (2025) Vol. Volume 17, pp. 1-10
Open Access | Times Cited: 1
Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells
Amalia Kotsifaki, Sousanna Maroulaki, Athanasios Armakolas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4832-4832
Open Access | Times Cited: 8
Amalia Kotsifaki, Sousanna Maroulaki, Athanasios Armakolas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4832-4832
Open Access | Times Cited: 8
Rat Models of Hormone Receptor-Positive Breast Cancer
Raquel Nicotra, Catrin Lutz, Hendrik A. Messal, et al.
Journal of Mammary Gland Biology and Neoplasia (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Raquel Nicotra, Catrin Lutz, Hendrik A. Messal, et al.
Journal of Mammary Gland Biology and Neoplasia (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7
Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 7
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 7
The roles of patient‐derived xenograft models and artificial intelligence toward precision medicine
Venkatachalababu Janitri, K.N. ArulJothi, Vijay Murali Ravi Mythili, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
Venkatachalababu Janitri, K.N. ArulJothi, Vijay Murali Ravi Mythili, et al.
MedComm (2024) Vol. 5, Iss. 10
Open Access | Times Cited: 6
Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 654-654
Open Access | Times Cited: 5
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 654-654
Open Access | Times Cited: 5
LncRNA GAS6-AS1 contributes to 5-fluorouracil resistance in colorectal cancer by facilitating the binding of PCBP1 with MCM3
Zhonglin Zhu, Minghan Li, Junyong Weng, et al.
Cancer Letters (2024) Vol. 589, pp. 216828-216828
Open Access | Times Cited: 4
Zhonglin Zhu, Minghan Li, Junyong Weng, et al.
Cancer Letters (2024) Vol. 589, pp. 216828-216828
Open Access | Times Cited: 4
In vitro and in vivo experimental models for cancer immunotherapy study
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100210-100210
Open Access | Times Cited: 4
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Current Research in Biotechnology (2024) Vol. 7, pp. 100210-100210
Open Access | Times Cited: 4
Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 4
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 4
Small Fish, Big Answers: Zebrafish and the Molecular Drivers of Metastasis
Mayra Fernanda Martínez-López, José Francisco López‐Gil
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 871-871
Open Access
Mayra Fernanda Martínez-López, José Francisco López‐Gil
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 871-871
Open Access
Nanoparticle-Mediated mRNA Delivery to Triple-Negative Breast Cancer (TNBC) Patient-Derived Xenograft (PDX) Tumors
Sara El‐Sahli, Shireesha Manturthi, Emma Durocher, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Sara El‐Sahli, Shireesha Manturthi, Emma Durocher, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Establishment and Its Utility of a Patient-Derived Cell Xenografts (PDCX) Model with Cryopreserved Cancer Cells from Human Tumor
Ki Yeon Kim, Ji Min Lee, Eun Ji Lee, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 325-325
Open Access
Ki Yeon Kim, Ji Min Lee, Eun Ji Lee, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 325-325
Open Access
Synergistic drug combination screening using a nanodroplet processing platform to enhance neuroblastoma treatment in TH ‐MYCN transgenic mice
Yen‐Tzu Liao, Zhi‐Kai Yu, Yi‐Xun Huang, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Yen‐Tzu Liao, Zhi‐Kai Yu, Yi‐Xun Huang, et al.
Bioengineering & Translational Medicine (2025)
Open Access
Patient-derived xenograft models: Current status, challenges, and innovations in cancer research
Min Liu, Xiaoping Yang
Genes & Diseases (2025), pp. 101520-101520
Open Access
Min Liu, Xiaoping Yang
Genes & Diseases (2025), pp. 101520-101520
Open Access
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting
Martina A. McAteer, Daniel R. McGowan, Gary Cook, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Martina A. McAteer, Daniel R. McGowan, Gary Cook, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Advances and Challenges in Human 3D Solid Tumor Models
Naveen Natesh, Shyni Varghese
Advanced Functional Materials (2025)
Closed Access
Naveen Natesh, Shyni Varghese
Advanced Functional Materials (2025)
Closed Access
Differences in treatment outcome between translational platforms in developing therapies for gastrointestinal cancers.
Katarzyna Wawrzak-Pienkowska, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, et al.
European Journal of Pharmacology (2025), pp. 177309-177309
Closed Access
Katarzyna Wawrzak-Pienkowska, Tomasz Pienkowski, Anna Tankiewicz‐Kwedlo, et al.
European Journal of Pharmacology (2025), pp. 177309-177309
Closed Access
Methods for Preclinical Assessment of the Efficacy of Anticancer Medicines in vivo (Review)
M. L. Vasyutina, Kirill V. Lepik, Maria S. Istomina, et al.
Regulâtornye issledovaniâ i èkspertiza lekarstvennyh sredstv. (2025)
Open Access
M. L. Vasyutina, Kirill V. Lepik, Maria S. Istomina, et al.
Regulâtornye issledovaniâ i èkspertiza lekarstvennyh sredstv. (2025)
Open Access
Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine
Breanna Mann, Nichole Artz, Rami Darawsheh, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Breanna Mann, Nichole Artz, Rami Darawsheh, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma
Shen Tian, Zhuang-Yu Hao, Denghui Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Shen Tian, Zhuang-Yu Hao, Denghui Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
In vitro models: Can they unravel the complexities of cancer cell metastasis?
Stefanos Pafitanis, Lefteris C. Zacharia, Andreas Stylianou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189293-189293
Closed Access
Stefanos Pafitanis, Lefteris C. Zacharia, Andreas Stylianou, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189293-189293
Closed Access
Optimization of In-Situ Exosome Enrichment Methodology On-a-Chip to Mimic Tumor Microenvironment Induces Cancer Stemness in Glioblastoma Tumor Model
Saleheh Saffar, Ali Ghiaseddin, Shiva Irani, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 676-676
Open Access
Saleheh Saffar, Ali Ghiaseddin, Shiva Irani, et al.
Cells (2025) Vol. 14, Iss. 9, pp. 676-676
Open Access
Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Giada De Lazzari, Alena Opattová, Sabrina Arena
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2